Juan Carlos
Montero González
Investigador desde 2021
University of Toronto
Toronto, CanadáPublicaciones en colaboración con investigadores/as de University of Toronto (3)
2016
-
Neuregulin expression in solid tumors: Prognostic value and predictive role to anti-HER3 therapies
Oncotarget, Vol. 7, Núm. 29, pp. 45042-45051
2015
-
Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancer
Oncotarget, Vol. 6, Núm. 29, pp. 27923-27937
2014
-
Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer
Oncogene, Vol. 33, Núm. 2, pp. 148-156